NG
Goossens, Nicolas
Affiliation entities
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Reintegration Into the Workforce After Kidney Transplantation Based on Urbanization Status in Switzerland | Kidney International Reports | 2025 | 90 | 92 | |||
| Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis | Kidney international reports | 2025 | 40 | 36 | |||
| Surgical site infections, risk factors, and outcomes after liver transplant | JAMA network open | 2025 | 60 | 60 | |||
| Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation : An international retrospective cohort study | Hepatology | 2025 | 74 | 274 | |||
| Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study | BMC infectious diseases | 2024 | 60 | 74 | |||
| Do infectious diseases after kidney retransplantation differ from those after first kidney transplantation ? | Open forum infectious diseases | 2024 | 108 | 57 | |||
| Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients | Transplant international | 2024 | 108 | 64 | |||
| BK polyomavirus serotype-specific antibody responses in blood donors and kidney transplant recipients with and without new-onset BK polyomavirus-DNAemia : A Swiss Transplant Cohort Study | American journal of transplantation | 2024 | 44 | 71 | |||
| Élévation des tests hépatiques et maladies stéatosiques du foie : nouveautés 2024 | Revue médicale suisse | 2024 | 49 | 0 | |||
| Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3) | The journal of infectious diseases | 2024 | 512 | 414 | |||
| Surgical site infections after kidney transplantation are independently associated with graft loss | American journal of transplantation | 2024 | 48 | 76 | |||
| Frequency and impact on renal transplant outcomes of urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species | Frontiers in medicine | 2024 | 82 | 17 | |||
| Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation : a longitudinal retrospective multicenter study | Bone marrow transplantation | 2024 | 76 | 36 | |||
| Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study | Frontiers in immunology | 2023 | 154 | 40 | |||
| Clinical prediction model for prognosis in kidney transplant recipients (KIDMO) : study protocol | Diagnostic and prognostic research | 2023 | 73 | 96 | |||
| Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | 2023 | 167 | 69 | |||
| A global research priority agenda to advance public health responses to fatty liver disease | Journal of hepatology | 2023 | 116 | 178 | |||
| ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance | Scientific reports | 2023 | 171 | 77 | |||
| Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2) | Open forum infectious diseases | 2023 | 85 | 52 | |||
| Discontinuation of immunosuppression in patients with immune-mediated drug-induced liver injury or idiopathic autoimmune hepatitis: a case-control study | JGH open | 2023 | 95 | 67 | |||
| Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2) | Open forum infectious diseases | 2023 | 137 | 62 | |||
| A multi–society Delphi consensus statement on new fatty liver disease nomenclature | Journal of hepatology | 2023 | 128 | 414 | |||
| Variable Intrafamilial Expression of ABCB4 Disease | ACG case reports journal | 2023 | 83 | 62 | |||
| Abdominal pain patterns during COVID-19: an observational study | Scientific reports | 2022 | 302 | 90 | |||
| Impact of Maternal Obesity on Liver Disease in the Offspring: A Comprehensive Transcriptomic Analysis and Confirmation of Results in a Murine Model | Biomedicines | 2022 | 491 | 231 | |||
| Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients | BMC infectious diseases | 2022 | 138 | 64 | |||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | 2022 | 239 | 99 | |||
| NAFLD and MAFLD as emerging causes of HCC: a populational study | JHEP Reports : Innovation in hepathology | 2021 | 320 | 216 | |||
| Impact of nonalcoholic steatohepatitis on the outcome of patients undergoing roux-en-y gastric bypass surgery: a propensity score-matched analysis | Obesity Surgery | 2021 | 223 | 89 | |||
| Clinical presentation and gene expression of acute alcohol-induced microvesicular steatosis mimicking alcoholic hepatitis | Hepatology Communications | 2021 | 246 | 115 | |||
| Management of acute Wilsonian hepatitis with severe hemolysis: a successful combination of chelation and MARS dialysis | Case Reports in Hepatology | 2021 | 238 | 139 | |||
| Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS) | Journal of Hepatology | 2021 | 245 | 0 | |||
| Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies | Journal of Hepatology | 2020 | 317 | 1 | |||
| Reply to: "Cirrhotic controls in a pooled analysis of hepatitis D and hepatocellular carcinoma" | Journal of Hepatology | 2020 | 229 | 124 | |||
| Management of hepatocellular carcinoma: SASL expert opinion statement | Swiss Medical Weekly | 2020 | 308 | 133 | |||
| Disulfiram-induced acute liver injury | Case Reports in Dermatology Hepatology | 2020 | 417 | 163 | |||
| Contribution of big data to biomarker and therapeutic discovery in liver disease | 2019 | 529 | 28 | ||||
| RB519, RB520, RB521 and RB522 antibodies recognize the human ISOC1 protein by ELISA | Antibody Reports | 2019 | 361 | 96 | |||
| Endovascular Treatment of Arterial Complications After Liver Transplantation: Long-Term Follow-Up Evaluated on Doppler Ultrasound and Magnetic Resonance Cholangiopancreatography | Cardiovascular and Interventional Radiology | 2019 | 322 | 394 | |||
| Chirurgie abdominale chez les malades avec hypertension portale : implications et prise en charge | Revue médicale suisse | 2019 | 425 | 280 | |||
| Activation of the oncogenic miR-21-5p promotes HCV replication and steatosis induced by the viral core 3a protein | Liver International | 2019 | 457 | 300 | |||
| Nonalcoholic fatty liver disease burden | Swiss Medical Weekly | 2019 | 312 | 164 | |||
| Tolerogenic propreties of liver macrophages in non-alcoholic steatohepatitis | Liver International | 2019 | 471 | 503 | |||
| Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease | World Journal of Hepatology | 2018 | 440 | 288 | |||
| A return to harmful alcohol consumption impacts on portal hemodynamic changes following alcoholic hepatitis | European Journal of Gastroenterology and Hepatology | 2018 | 458 | 3 | |||
| Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review | Journal of Viral Hepatitis | 2018 | 529 | 0 | |||
| Cardiovascular Manifestations of Hepatitis C Virus | Clinics in Liver Disease | 2017 | 487 | 2 | |||
| Hépatite B : nouvelles recommandations de prise en charge | Revue médicale suisse | 2017 | 578 | 2 | |||
| Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review | Journal of Advanced Research | 2017 | 516 | 360 | |||
| Combination of Gene Expression Signature and Model for End-stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis | Gastroenterology | 2017 | 596 | 2 | |||
| Liver volume is a prognostic indicator for clinical outcome of patients with alcoholic hepatitis | Abdominal radiology | 2017 | 640 | 82 | |||
| Hepatic protein tyrosine phosphatase receptor gamma links obesity-induced inflammation to insulin resistance | Nature Communications | 2017 | 1,550 | 404 | |||
| Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease | Nutrients | 2017 | 488 | 0 | |||
| Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns? | Stem cell research & therapy | 2017 | 557 | 217 | |||
| Facteurs hépatiques pronostiques à long terme après chirurgie bariatrique | 2017 | 530 | 7 | ||||
| Peribiliary Gland Dilatation in Cirrhosis: Relationship with Liver Failure and Stem Cell/Proliferation Markers | Digestive diseases and sciences | 2017 | 633 | 1 | |||
| Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery | Clinical gastroenterology and hepatology | 2016 | 540 | 0 | |||
| Drug Pricing Evolution in Hepatitis C | PloS one | 2016 | 1,365 | 609 | |||
| Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis | Journal of hepatology | 2015 | 610 | 2 | |||
| DOME/GALT type adenocarcimoma of the colon: a case report, literature review and a unified phenotypic categorization | Diagnostic pathology | 2015 | 579 | 198 | |||
| Repenser la politique de remboursement des agents antiviraux directs contre l'hépatite C chronique | Revue médicale suisse | 2015 | 542 | 1 | |||
| Extrahepatic manifestations of HCV | Minerva gastroenterologica e dietologica | 2015 | 545 | 0 | |||
| Is genotype 3 of the hepatitis C virus the new villain ? | Hepatology | 2014 | 343 | 0 | |||
| The impact of obesity and metabolic syndrome on chronic hepatitis C | Clinics in liver disease | 2014 | 562 | 0 | |||
| Insulin resistance, non-alcoholic fatty liver disease and hepatitis C virus infection | Reviews on recent clinical trials | 2014 | 560 | 0 | |||
| Morbidité et mortalité extrahépatiques associées à l'infection par le virus de l'hépatite C | Revue médicale suisse | 2014 | 551 | 1 | |||
| Severe immune-mediated drug-induced liver injury linked to ibandronate: a case report | Journal of Hepatology | 2013 | 619 | 0 | |||
| Réactivation de l'hépatite B au cours de l'immunosuppression | Revue médicale suisse | 2013 | 585 | 0 | |||
| IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes | Hepatology | 2012 | 654 | 0 | |||
| A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis | BMC gastroenterology | 2011 | 715 | 337 | |||
| Nouveaux traitements de l'hépatite C : quelles cibles, quel calendrier? | Revue médicale suisse | 2011 | 525 | 0 | |||
| Role of nucleotides and phosphoinositides in the stability of electron and proton currents associated with the phagocytic NADPH oxidase | Biochemical journal | 2006 | 694 | 304 |
